Mark J. Salji

929 total citations
23 papers, 481 citations indexed

About

Mark J. Salji is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Mark J. Salji has authored 23 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 10 papers in Molecular Biology and 9 papers in Cancer Research. Recurrent topics in Mark J. Salji's work include Prostate Cancer Treatment and Research (12 papers), Cancer, Lipids, and Metabolism (7 papers) and Prostate Cancer Diagnosis and Treatment (5 papers). Mark J. Salji is often cited by papers focused on Prostate Cancer Treatment and Research (12 papers), Cancer, Lipids, and Metabolism (7 papers) and Prostate Cancer Diagnosis and Treatment (5 papers). Mark J. Salji collaborates with scholars based in United Kingdom, Canada and Norway. Mark J. Salji's co-authors include Hing Y. Leung, Catherine Winchester, Laura C.A. Galbraith, Imran Ahmad, Ana M. Pérez‐López, Belén Rubio‐Ruíz, Thomas L. Bray, Asier Unciti‐Broceta, Alessandro Brombin and E. Elizabeth Patton and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Mark J. Salji

23 papers receiving 475 citations

Peers

Mark J. Salji

PRM

ONCOL

Joshua Prey United States

Che Zhang China

Pavani Chalasani United States

Emilia Bigaeva Netherlands

W J van der Vijgh Netherlands

Gerlie Gieser United States

Antonella Pietragalla Italy

Christine Williamson United Kingdom

Xuchao Wang China

Ciska Verbaanderd Belgium

Joshua Prey United States

Mark J. Salji

242 ×1.0

90 ×0.8

PRM

43 ×0.4

14 ×0.2

113 ×2.1

ONCOL

Citations per year, relative to Mark J. Salji Mark J. Salji (= 1×) peers Joshua Prey

Countries citing papers authored by Mark J. Salji

Since Specialization

Citations

This map shows the geographic impact of Mark J. Salji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Salji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Salji more than expected).

Fields of papers citing papers by Mark J. Salji

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark J. Salji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Salji. The network helps show where Mark J. Salji may publish in the future.

Co-authorship network of co-authors of Mark J. Salji

This figure shows the co-authorship network connecting the top 25 collaborators of Mark J. Salji. A scholar is included among the top collaborators of Mark J. Salji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark J. Salji. Mark J. Salji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Leung, Hing Y., et al.. (2023). A contemporary analysis of disease upstaging of Gleason 3 + 3 prostate cancer patients after robot‐assisted laparoscopic prostatectomy. Cancer Medicine. 12(22). 20830–20837. 2 indexed citations

Adam, Catherine, Thomas L. Bray, Ana M. Pérez‐López, et al.. (2022). A 5-FU Precursor Designed to Evade Anabolic and Catabolic Drug Pathways and Activated by Pd Chemistry In Vitro and In Vivo. Journal of Medicinal Chemistry. 65(1). 552–561. 31 indexed citations

Sandilands, Emma, Matthew Neilson, Álvaro Román‐Fernández, et al.. (2022). Traject3d allows label-free identification of distinct co-occurring phenotypes within 3D culture by live imaging. Nature Communications. 13(1). 5317–5317. 16 indexed citations

Connell, Shea P., Maria Frantzi, Agnieszka Latosińska, et al.. (2022). A Model to Detect Significant Prostate Cancer Integrating Urinary Peptide and Extracellular Vesicle RNA Data. Cancers. 14(8). 1995–1995. 10 indexed citations

Rushworth, Linda, Carolyn J. Loveridge, Mark J. Salji, et al.. (2022). Phase II proof‐of‐concept study of atorvastatin in castration‐resistant prostate cancer. British Journal of Urology. 131(2). 236–243. 5 indexed citations

Salji, Mark J., Arnaud Blomme, J. Henry M. Däbritz, et al.. (2022). Multi-omics & pathway analysis identify potential roles for tumor N-acetyl aspartate accumulation in murine models of castration-resistant prostate cancer. iScience. 25(4). 104056–104056. 6 indexed citations

Ntala, Chara, Mark J. Salji, Jonathan Salmond, et al.. (2021). Analysis of Prostate Cancer Tumor Microenvironment Identifies Reduced Stromal CD4 Effector T-cell Infiltration in Tumors with Pelvic Nodal Metastasis. European Urology Open Science. 29. 19–29. 10 indexed citations

Grudniewska, Magda, Mark J. Salji, Matti Nykter, et al.. (2021). Gene Regulation Network Analysis on Human Prostate Orthografts Highlights a Potential Role for the JMJD6 Regulon in Clinical Prostate Cancer. Cancers. 13(9). 2094–2094. 5 indexed citations

Malviya, Gaurav, Rachana Patel, Mark J. Salji, et al.. (2020). 18F-Fluciclovine PET metabolic imaging reveals prostate cancer tumour heterogeneity associated with disease resistance to androgen deprivation therapy. EJNMMI Research. 10(1). 143–143. 17 indexed citations

10.

Connell, Shea P., Maria Frantzi, Agnieszka Latosińska, et al.. (2019). Detecting clinically significant prostate cancer with urine: A multivariable risk model integrating urinary proteomic and cell-free RNA data. European Urology Supplements. 18(8). e3150–e3150. 1 indexed citations

11.

Patel, Rachana, Janis Fleming, Ernest Mui, et al.. (2018). Sprouty2 loss‐induced IL 6 drives castration‐resistant prostate cancer through scavenger receptor B1. EMBO Molecular Medicine. 10(4). 21 indexed citations

12.

Bray, Thomas L., Mark J. Salji, Alessandro Brombin, et al.. (2018). Bright insights into palladium-triggered local chemotherapy. Chemical Science. 9(37). 7354–7361. 86 indexed citations

13.

Galazi, Myria, et al.. (2018). Effect of HER3 dimer feedback upregulation via PI3K-AKT-mTOR pathway inhibition on androgen receptor (AR) stabilization in metastatic prostate cancer.. Journal of Clinical Oncology. 36(6_suppl). 226–226. 1 indexed citations

14.

Salji, Mark J., Jane Hendry, Amit Patel, et al.. (2017). Peri-prostatic Fat Volume Measurement as a Predictive Tool for Castration Resistance in Advanced Prostate Cancer. European Urology Focus. 4(6). 858–866. 30 indexed citations

15.

Loveridge, Carolyn J., Rob vanʼt Hof, Ayala King, et al.. (2017). Analysis of Nkx3.1:Cre-driven Erk5 deletion reveals a profound spinal deformity which is linked to increased osteoclast activity. Scientific Reports. 7(1). 13241–13241. 11 indexed citations

16.

Salji, Mark J., Imran Ahmad, & Catherine Winchester. (2016). Non-clinical research – laboratory based. Journal of Clinical Urology. 9(6). 362–364. 1 indexed citations

17.

Ahmad, Imran, Ernest Mui, Laura C.A. Galbraith, et al.. (2016). Sleeping Beautyscreen revealsPpargactivation in metastatic prostate cancer. Proceedings of the National Academy of Sciences. 113(29). 8290–8295. 87 indexed citations

18.

Stather, Philip, Mark J. Salji, Mustafa Abbas, et al.. (2016). A comparison of airborne bacterial fallout between orthopaedic and vascular surgery. Annals of The Royal College of Surgeons of England. 99(4). 295–298. 1 indexed citations

19.

Kosmoliaptsis, Vasilis, Mark J. Salji, Victoria Bardsley, et al.. (2015). Baseline Donor Chronic Renal Injury Confers the Same Transplant Survival Disadvantage for DCD and DBD Kidneys. American Journal of Transplantation. 15(3). 754–763. 38 indexed citations

20.

Salji, Mark J., Robert J. Jones, James Paul, et al.. (2014). Feasibility study of a randomised controlled trial to compare (deferred) androgen deprivation therapy and cryotherapy in men with localised radiation-recurrent prostate cancer. British Journal of Cancer. 111(3). 424–429. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact